Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion? - Report - MDSpire

Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion?

  • By

  • Martina Romanisio

  • Chiara Mele

  • Sara Sturnia

  • Carola Ciamparini

  • Rosa Pitino

  • Alice Ferrero

  • Lorenza Scotti

  • Madalina Elena Iftimie

  • Gianluca Aimaretti

  • Paolo Marzullo

  • Flavia Prodam

  • Marina Caputo

  • April 30, 2026

  • 0 min

Share

Clinical Report: Is Muscle Strength an Underappreciated Factor in Patients with Mild Autonomous Cortisol Secretion?

Overview

This study evaluates the impact of mild autonomous cortisol secretion (MACS) on muscle strength, body composition, and quality of life in patients with adrenal incidentalomas. Findings indicate that MACS is associated with a higher prevalence of osteopenia and osteoporosis, as well as reduced muscle strength compared to non-functioning adrenal adenomas and healthy controls.

Background

Expand on the implications of MACS on muscle health and clarify the controversy regarding muscle strength reduction.

Data Highlights

GroupOsteopenia/Osteoporosis PrevalenceMRC Score (Biceps/Quadriceps)
MACS61.9%Reduced
NFAA28.6%Normal
Controls25%Normal

Key Findings

  • Patients with MACS had a significantly higher prevalence of osteopenia and osteoporosis (61.9%) compared to NFAA (28.6%) and controls (25%).
  • Reduced muscle strength was observed in MACS patients, with significantly lower MRC scores for biceps and quadriceps compared to controls (p=0.04).
  • No significant differences in fat-free mass, muscle mass, or fat mass were found among the groups.
  • Quality of life scores showed a trend toward greater impairment in the MACS group.
  • Higher post-dexamethasone suppression test cortisol concentrations were noted in patients with osteoporosis/osteopenia and reduced muscle strength.

Clinical Implications

Clinicians should be aware of the potential musculoskeletal impacts of mild autonomous cortisol secretion, particularly the increased risk of osteopenia and reduced muscle strength. Routine assessment of bone health and muscle function may be warranted in patients diagnosed with MACS to mitigate associated health risks.

Conclusion

This study highlights the under-recognized musculoskeletal effects of mild hypercortisolism, emphasizing the need for further research and clinical attention to muscle strength in patients with MACS.

References

  1. Frontiers in Endocrinology, 2026 -- Reassessing the Adrenal Stress Index: Understanding Neutrophil-Driven Glucocorticoid Resistance Beyond Adrenal Fatigue
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Diminishing Kidney Function Linked to Progressive Insufficiency of 11β-Hydroxysteroid Dehydrogenase Type 2
  3. Endocrine Reviews, 2023 -- Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities
  4. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Circadian Patterns of Cortisol Secretion and Steroid Metabolome Analysis in Individuals with Mild Autonomous Cortisol Secretion: A Cross-Sectional Investigation
  5. Adrenalectomy improves cardiovascular profile in patients with mild autonomous cortisol secretion: extension of a multicenter randomized controlled trial to 12 months | Journal of Endocrinological Investigation
  6. Adrenalectomy Improves Muscle Strength in Patients with Mild Autonomous Cortisol Secretion: A Comparative Study | MDPI
  7. European Society of Endocrinology/ENSAT Guidelines
  8. Adrenalectomy improves cardiovascular profile in patients with mild autonomous cortisol secretion: extension of a multicenter randomized controlled trial to 12 months | Journal of Endocrinological Investigation | Springer Nature Link
  9. Adrenalectomy Improves Muscle Strength in Patients with Mild Autonomous Cortisol Secretion: A Comparative Study | MDPI

Original Source(s)

Related Content